FDA Approves Medtronic Low Glucose Suspend

"MINNEAPOLIS – September 27, 2013 –Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval of the MiniMed® 530G with Enlite®, a breakthrough, first-generation artificial pancreas system with Threshold Suspend..."

Read the rest of this exciting press release at the link.

Loading the Elevenlabs Text to Speech AudioNative Player...
Previous
Previous

Helping Children with Diabetes Gain Independence

Next
Next

In Need of a Vacuum Cleaner Recommendation